Correlation Between Millennium Pharmacon and Diagnos Laboratorium

Can any of the company-specific risk be diversified away by investing in both Millennium Pharmacon and Diagnos Laboratorium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Millennium Pharmacon and Diagnos Laboratorium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Millennium Pharmacon International and Diagnos Laboratorium Utama, you can compare the effects of market volatilities on Millennium Pharmacon and Diagnos Laboratorium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Millennium Pharmacon with a short position of Diagnos Laboratorium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Millennium Pharmacon and Diagnos Laboratorium.

Diversification Opportunities for Millennium Pharmacon and Diagnos Laboratorium

-0.36

Correlation Coefficient

Millennium Pharmacon  Diagnos Laboratorium

Very good diversification

The 3 months correlation between Millennium and Diagnos is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Millennium Pharmacon Internati and Diagnos Laboratorium Utama in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diagnos Laboratorium and Millennium Pharmacon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Millennium Pharmacon International are associated (or correlated) with Diagnos Laboratorium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diagnos Laboratorium has no effect on the direction of Millennium Pharmacon i.e., Millennium Pharmacon and Diagnos Laboratorium go up and down completely randomly.

Pair Corralation between Millennium Pharmacon and Diagnos Laboratorium

Assuming the 90 days trading horizon Millennium Pharmacon International is expected to generate 1.05 times more return on investment than Diagnos Laboratorium. However, Millennium Pharmacon is 1.05 times more volatile than Diagnos Laboratorium Utama. It trades about 0.02 of its potential returns per unit of risk. Diagnos Laboratorium Utama is currently generating about -0.12 per unit of risk. If you would invest  13,600  in Millennium Pharmacon International on September 17, 2024 and sell it today you would earn a total of  100.00  from holding Millennium Pharmacon International or generate 0.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Millennium Pharmacon Internati  vs.  Diagnos Laboratorium Utama

Millennium Pharmacon

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Millennium Pharmacon International are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward-looking signals, Millennium Pharmacon is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Diagnos Laboratorium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Diagnos Laboratorium Utama has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Millennium Pharmacon and Diagnos Laboratorium

The main advantage of trading using opposite Millennium Pharmacon and Diagnos Laboratorium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Millennium Pharmacon position performs unexpectedly, Diagnos Laboratorium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnos Laboratorium will offset losses from the drop in Diagnos Laboratorium's long position.

The idea behind Millennium Pharmacon International and Diagnos Laboratorium Utama pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.